logo-loader
RNS
AdvancedAdvT Ltd

AdvancedAdvT Limited - Purchase of Own Shares

RNS Number : 9505O
AdvancedAdvT Limited
03 August 2026
 

This announcement contains inside information
for the purposes of UK Market Abuse Regulation.

3 August 2026

AdvancedAdvT Limited

Purchase of Own Shares

 

AdvancedAdvT Limited (AIM: ADVT, "AdvT", the "Group", the "Company"), the international software solutions provider for the business solutions, healthcare compliance, and human capital management sectors, announces that further to the confirmation of its intention to implement a share buyback programme, as set out in its announcement on 4 March 2026, in the period from 27 July 2026 up to and including 31 July 2026 it purchased a further 94,000 of its ordinary shares of no par value in the capital of the Company ("Ordinary Shares"). The Ordinary Shares purchased will be held in treasury.

 

Following this purchase, the cumulative number of Ordinary Shares bought under this programme now totals 5,434,500.

 

Aggregated information

 

Date of purchase

Number of Ordinary Shares purchased

Highest price paid per Ordinary Share

Lowest price paid per Ordinary Share

Volume Weighted price paid per Ordinary Share

27 July 2026

39,000

173.00p

170.31p

171.75p

28 July 2026

10,000

170.91p

170.00p

170.46p

29 July 2026

10,000

171.25p

171.25p

171.25p

30 July 2026

10,000

170.35p

170.35p

170.35p

31 July 2026

25,000

173.00p

173.00p

173.00p

 

Transaction details

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018), a detailed breakdown of individual trades is available below:

 

Date of purchase

Number of Ordinary Shares purchased

Transaction price (GBP)

Time of transaction

Trading venue

27 July 2026

20,000

173.00p

10:05

AIMX

27 July 2026

9,000

170.59p

13:43

AIMX

27 July 2026

10,000

170.31p

15:18

AIMX

28 July 2026

5,000

170.91p

15:54

AIMX

28 July 2026

5,000

170.00p

16:13

AIMX

29 July 2026

10,000

171.25p

15:59

AIMX

30 July 2026

10,000

170.35p

15:52

AIMX

31 July 2026

25,000

173.00p

13:16

AIMX

 

Total voting rights

 

Following the purchase, the Company's total issued share capital will consist of 137,125,806 Ordinary Shares each carrying one voting right, of which 5,434,500 Ordinary Shares are held in treasury. Therefore, the total number of Ordinary Shares carrying voting rights will be 131,691,306. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The person responsible for arranging the release of this Announcement
on behalf of the Company is
Gavin Hugill, Chief Financial Officer.

 

Enquiries:

AdvancedAdvT Limited


Vin Murria, Chairperson

Gavin Hugill, Chief Financial Officer




Singer Capital Markets (Nominated Adviser and Broker)

Tel: 020 7496 3000

James Moat / James Fischer




KK Advisory (Investor Relations)

Tel: 020 7039 1901

Kam Bansil 


 

Note to Editors

AdvancedAdvT Limited (AdvT) provides software solutions and platforms across two business transformational areas: business solutions & healthcare compliance, and human capital management.

AdvT is an agent for change. The Group enables the delivery of Artificial Intelligence ("AI"), data analytics and business intelligence, all of which are key future drivers for growth in these sectors where long term digitisation trends are set to transform the workplace for professionals. 

AdvT is developing both organically and through acquisitions, by expanding its presence across adjacent markets, geographical boundaries and digital sectors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSSUFAEEMSELA
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not registered in any category of registration under the securities legislation of any province or territory of Canada. Nothing in this record constitutes "advice" concerning investing in, buying, or selling a security within the meaning of applicable Canadian securities legislation. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after obtaining advice from a registrant authorised under the securities legislation of your province or territory.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship is for news distribution and media services only and does not determine, influence, or shape the editorial content produced.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

3 min read